• Home
  • MGMA TO CMS: RETURN TO DRAWING BOARD ON PART B DRUGS PAYMENT MODEL

MGMA TO CMS: RETURN TO DRAWING BOARD ON PART B DRUGS PAYMENT MODEL

05/10/2016 6:36 AM | Rebekah Francis (Administrator)
On Monday, MGMA sent a comment letter to the Centers for Medicare & Medicaid Services (CMS), urging the agency not to move forward with its proposed Part B drug payment program. The Association recommended the agency seek physician practice input to create a payment model that would support value-based reimbursement models and improve efficiency and quality in delivering physician-administered drugs, including life-saving treatments. MGMA expressed concern that the proposed payment model would establish a precedent under which the CMS Innovation Center could expand its limited legislative authority to circumvent the usual channels to change physician payment. MGMA also raised issue with the fact that this payment model would conflict with ongoing value-based initiatives under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Learn more about MACRA at MGMA’s MACRA Resource Center.


OUR GOAL

To develop and equip our members to create dynamic, successful medical group practices.

OUR VISION

To be the recognized leader in defining and supporting the profession of medical practice management in Missouri.

CONTACT US

PO Box 381533
Birmingham, AL 35238
Phone: (573) 556-6111
Fax: (877) 720-1495

Copyright 2016, MGMA-MO.org | info@mgma-mo.org